Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter

Cormorant added 313,645 Alumis shares in the first quarter, an estimated $7.84 million purchase based on average quarterly prices. The filing signals constructive investor positioning toward Alumis, a healthcare/biotech name, but the update is a routine ownership disclosure rather than a fundamental catalyst. Market impact should be limited unless followed by additional buying or company-specific news.

Analysis

Cormorant added 313,645 Alumis shares in the first quarter, an estimated $7.84 million purchase based on average quarterly prices. The filing signals constructive investor positioning toward Alumis, a healthcare/biotech name, but the update is a routine ownership disclosure rather than a fundamental catalyst. Market impact should be limited unless followed by additional buying or company-specific news.